Editorial Advisory Board
Nicolas Badre, MD, a board-certified psychiatrist, practices in San Diego. He is a forensic psychiatrist for the county of San Diego, a volunteer clinical faculty member at the University of California, San Diego, and a member of the teaching faculty at the University of San Diego. He also maintains a private practice. Dr. Badre enjoys studying and writing about the relationship between philosophy, ethics, social context, and psychiatry.
Daniel E. Casey, MD is professor of psychiatry and neurology at the Oregon Health and Science University, Portland. He has served as a member and chairman of the Food and Drug Administration's Psychopharmacologic Drugs Advisory Committee. Dr. Casey also has served as chief of psychiatric research and psychopharmacology at the Veterans Affairs Medical Center, Portland, Ore.
Steven R. Daviss, MD, DFAPA, is the senior medical advisor to the office of the chief medical officer within the Substance Abuse and Mental Health Services Administration in Rockville, Md., serving as an ex officio liaison. He is board-certified in psychiatry and in psychosomatic medicine, and previously was clinical assistant professor at the University of Maryland, Baltimore; president of the Maryland Psychiatric Society; and assembly recorder at the American Psychiatric Association.
Thelissa A. Harris, MD a diplomat of the American Board of Obesity Medicine, is in private
practice in adult and geriatric psychiatry in Hartford, Conn. She also works as a psychiatric consultant to continuing care retirement organizations and professional groups. Dr. Harris, a former president of the Black Psychiatrists of America, is a Distinguished Fellow of the American Psychiatric Association. Besides psychotherapy, her major clinical interests include geriatrics and the interface between general medicine and psychiatry.
Simon Kung, MD is medical director of the inpatient Mood Disorders Unit and for the
Transcranial Magnetic Stimulation program at the Mayo Clinic in Rochester, Minn. He also is an assistant professor of psychiatry in the department of psychiatry and psychology at the clinic. Dr. Kung's main area of interest is treatment-resistant depressive disorders, including pharmacologic treatments, pharmacogenetic testing, transcranial magnetic stimulation, and psychotherapies. He is also involved in developing computer applications to support clinical, education, research, and administrative aspects of psychiatry. Dr. Kung, a member of the American Association for Technology in Psychiatry, developed the first Mayo Medical School internal Web site.
Thomas W. Meeks, MD has served 3 years as an assistant professor of psychiatry at the University of California, San Diego. He holds a Certificate of Added Qualifications in Geriatric Psychiatry, and his work has been focused within the division of geriatric psychiatry. He received a National Alliance for Research on Schizophrenia and Depression Young Investigator Award to examine the potential additive role of inflammation in late-life depression and chronic pain, two illnesses he commonly sees in clinical practice. He also received a Geriatric Academic Career Award, which was designed to foster his skills as a clinician-educator. He chose to focus on enhancing his skills in bilingual/bicultural competency in working with Latino older adults suffering from dementia and other late-life mental illnesses, and their families.
Dinah Miller, M.D. is a psychiatrist and writer in Baltimore. She is in private practice, and
over the past 20 years has worked at four community psychiatry clinics in the greater Baltimore area. She is the coauthor of “Shrink Rap: Three Psychiatrists Explain Their Work,” as well as four novels. Along with Dr. Annette Hanson and Dr. Steven Roy Daviss, she is a cofounder of the Accessible Psychiatry Project, which includes the Shrink Rap blog and the My Three Shrinks Podcast. Dr. Miller recently left a consulting position of 15 years at the Johns Hopkins community psychiatry program to escape Epic and to work on a book on involuntary psychiatric treatments.
Theresa M. Miskimen, MD is vice president for medical services at University Behavioral
Healthcare, New Jersey's largest provider of behavioral health care services. She also serves as an associate professor in the department of psychiatry at the Robert Wood Johnson Medical School, UMDNJ. Over the years, Dr. Miskimen has spearheaded the formation of culturally competent treatment groups for Hispanic patients with severe and persistent mental illness. In addition, Dr. Miskimen serves as a co-investigator in a multisite National Institute of Mental Health-funded study on ethnicity and the diagnosis of affective illness. Dr. Miskimen is a Distinguished Life Fellow of the American Psychiatric Association and served as president of the New Jersey Psychiatric Association from 2009 to 2010.
Clifford K. Moy, MD is medical director for Behavioral Health at the TMF Health Quality Institute, Austin. He is a delegate to the American Medical Association's House of Delegates and was appointed to the Malcolm Baldrige National Quality Award Board of Examiners for 2006 and 2007. In addition, Dr. Moy serves on the Texas Medical Association Council on Medical Education and the Travis County Medical Society Board of Ethics.
Rodrigo A. Muñoz, MD is clinical professor of psychiatry at the University of California, San
Diego. He has published scientific papers in most of the leading psychiatric journals in the country. In addition, he has held numerous leadership positions, including president of the American Psychiatric Association and of the San Diego County Medical Society. Dr. Muñoz is active in programs serving the indigent, the homeless, and patients who suffer from chronic mental illness.
Anthony T. Ng, MD is an assistant professor of psychiatry at the Uniformed Services University of Health Services and the George Washington University School of Medicine, Washington. He currently serves as medical director of psychiatric emergency services at Acadia Hospital, Bangor, Maine. Dr. Ng has extensive experience in the area of primary care and mental health, crosscultural issues, community system issues, substance abuse and homeless issues, and disaster psychiatry. He also is involved in community mental health and emergency psychiatry. He is the immediate past president of the American Association of Emergency Psychiatry and is the former chairperson of the New York State Office of Mental Health Multicultural Advisory Committee.
Jay H. Shore, MD is the director of telemedicine at the University of Colorado’s Depression Center. He also serves an associate professor at the University of Colorado Denver’s department of psychiatry and in the School of Public Health’s Centers for American Indian and Alaska Native Health. His career has focused on the use of technology in mental health. He participates in multiple projects, including the ongoing development, implementation, and assessment of programs in Native, rural, and military settings aimed at improving quality and access to care.
Peter J. Weiden, MD is director of the Psychotic Disorders Program at the Center for Cognitive Medicine, department of psychiatry, University of Illinois at Chicago. Previously, he served as professor of psychiatry and director of the Schizophrenia Research Service at State University of New York Downstate Medical Center, Brooklyn. He has received several awards from family and patient advocacy groups and was named an Exemplary Psychiatrist on three occasions by the National Alliance for the Mentally Ill.
|Last updated October 2, 2017|